Table of Contents Author Guidelines Submit a Manuscript
Infectious Diseases in Obstetrics and Gynecology
Volume 2010 (2010), Article ID 705692, 6 pages
http://dx.doi.org/10.1155/2010/705692
Clinical Study

Treatment of Bacterial Vaginosis: A Multicenter, Double-Blind, Double-Dummy, Randomised Phase III Study Comparing Secnidazole and Metronidazole

1Institut Alfred Fournier, 25, Boulevard Saint-Jacques, 75014 Paris, France
2Hôpital Fernand Widal, 200 rue du Fbg Street Denis, 75010 Paris, France
3IPRAD 174, quai de Jemmapes, 75010 Paris, France

Received 23 April 2010; Accepted 14 July 2010

Academic Editor: José Tirán-Saucedo

Copyright © 2010 Jean-Marc Bohbot et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [11 citations]

The following is the list of published articles that have cited the current article.

  • Jean-Pierre Menard, “Antibacterial treatment of bacterial vaginosis: current and emerging therapies.,” International journal of women's health, vol. 3, pp. 295–305, 2011. View at Publisher · View at Google Scholar
  • Maria Elisabete A. Moraes, Gilmara H. Cunha, Mirna M. Bezerra, Francisco V. Fechine, Andréa V. Pontes, Wanda S. Andrade, Fernando A. Frota Bezerra, Manoel O. Moraes, and Pacífica P. Cavalcanti, “Efficacy of the Mentha crispa in the treatment of women with Trichomonas vaginalis infection,” Archives of Gynecology and Obstetrics, vol. 286, no. 1, pp. 125–130, 2012. View at Publisher · View at Google Scholar
  • Qian Chen, Jin Wang, He-Kun Mei, Nan Bai, Bei-Bei Liang, Xue-Wei Jiang, Hui Niu, Xiu-Zhen Di, Kai Wang, and Rui Wang, “Metabolism research progress of nitroimidazoles in human body,” Chinese Pharmaceutical Journal, vol. 50, no. 14, pp. 1169–1173, 2015. View at Publisher · View at Google Scholar
  • Daniela Machado, Joana Castro, Ana Palmeira-de-Oliveira, José Martinez-de-Oliveira, and Nuno Cerca, “Bacterial Vaginosis Biofilms: Challenges to Current Therapies and Emerging Solutions,” Frontiers in Microbiology, vol. 6, 2016. View at Publisher · View at Google Scholar
  • Jane R. Schwebke, Franklin G. Morgan, William Koltun, and Paul Nyirjesy, “A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis,” American Journal of Obstetrics and Gynecology, 2017. View at Publisher · View at Google Scholar
  • Sharon L. Hillier, Paul Nyirjesy, Arthur S. Waldbaum, Jane R. Schwebke, Franklin G. Morgan, Nikki A. Adetoro, and Carol J. Braun, “Secnidazole Treatment of Bacterial Vaginosis,” Obstetrics & Gynecology, vol. 130, no. 2, pp. 379–386, 2017. View at Publisher · View at Google Scholar
  • Melinda A.B. Petrina, Lisa A. Cosentino, Lorna K. Rabe, and Sharon L. Hillier, “Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, tinidazole and clindamycin,” Anaerobe, 2017. View at Publisher · View at Google Scholar
  • Sevil Hakimi, Faranak Farhan, Azizeh Farshbaf-Khalili, Parvin Dehghan, Yousef Javadzadeh, Shamsi Abbasalizadeh, and Bagher Khalvati, “The effect of prebiotic vaginal gel with adjuvant oral metronidazole tablets on treatment and recurrence of bacterial vaginosis: a triple-blind randomized controlled study,” Archives of Gynecology and Obstetrics, 2017. View at Publisher · View at Google Scholar
  • Toktam Dokhanchi, Lida Takallu, Sakineh Mohammad-Alizadeh, Sevil Hakimi, Yusef Javadzadeh, and Parvin Mostafa Gharabaghi, “The addition of vitamin C vaginal tablets to oral metronidazole and its effect on the treatment and recurrence of bacterial vaginosis: A randomized triple-blind clinical trial,” International Journal of Women's Health and Reproduction Sciences, vol. 5, no. 3, pp. 193–199, 2017. View at Publisher · View at Google Scholar
  • Paul Nyirjesy, and Jane R Schwebke, “Secnidazole: next-generation antimicrobial agent for bacterial vaginosis treatment,” Future Microbiology, 2018. View at Publisher · View at Google Scholar
  • Steven E. Chavoustie, Janet K. Gersten, Milroy J. Samuel, and Jane R. Schwebke, “A Phase 3, Multicenter, Prospective, Open-Label Study to Evaluate the Safety of a Single Dose of Secnidazole 2 g for the Treatment of Women and Postmenarchal Adolescent Girls with Bacterial Vaginosis,” Journal of Women's Health, 2018. View at Publisher · View at Google Scholar